Description: Immunovia AB (publ), a diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company's product includes IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. It also develops research projects for lung cancer. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Home Page: www.immunovia.com
Medicon Village
Lund,
223 63
Sweden
Phone:
46 4 62 75 60 00
Officers
| Name | Title |
|---|---|
| Mr. Philipp Mathieu | CEO & Pres |
| Ms. Karin Almqvist Liwendahl | Chief Financial Officer |
| Mr. Jeff Borcherding | Chief Exec. Officer of US, Immunovia, Inc. |
| Ms. Linda Dexlin Mellby | VP of R&D |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.2138 |
| Price-to-Sales TTM: | 683.4729 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 64 |